74 Publications (Page 2 of 3)
2014
Comparison of an assumption-free Bayesian approach with Optimal Sampling Schedule to a maximum a posteriori Approach for Personalizing Cyclophosphamide Dosing.
Laínez, José M⋅Orcun, Seza⋅Pekny, Joseph F⋅Reklaitis, Gintaras V⋅Suvannasankha, Attaya⋅Fausel, Christopher⋅Anaissie, Elias J and Blau, Gary E
Pharmacotherapy, vol. 34, (no. 4), pp. 330-5, 2014/Apr. | Journal Article
 
Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15.
Timani, Khalid Amine⋅Liu, Ying⋅Suvannasankha, Attaya and He, Johnny J
The international journal of biochemistry & cell biology, vol. 54, pp. 10-19, September 2014. | Journal Article
 
Role of bone-anabolic agents in the treatment of breast cancer bone metastases.
Suvannasankha, Attaya and Chirgwin, John M
Breast cancer research : BCR, vol. 16, (no. 6), pp. 484, 2014. | Journal Article
 
Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
Siclari, Valerie A⋅Mohammad, Khalid S⋅Tompkins, Douglas R⋅Davis, Holly⋅McKenna, C Ryan⋅Peng, Xianghong⋅Wessner, Lisa L⋅Niewolna, Maria⋅Guise, Theresa A⋅Suvannasankha, Attaya and Chirgwin, John M
Breast cancer research : BCR, vol. 16, (no. 6), pp. 458, December 2, 2014. | Journal Article
2013
Neonatal Mouse Bone Supports Growth Of Primary Myeloma Cells Ex Vivo and Assessment Of Responses To Antimyeloma Drugs
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Tompkins, Douglas R⋅Tompkins, Douglas R⋅Tompkins, Douglas R⋅Petyaykina, Kateryna⋅Petyaykina, Kateryna⋅Petyaykina, Kateryna⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Condon, Keith W⋅Condon, Keith W⋅Condon, Keith W⋅David Roodman, G. David⋅David Roodman, G. David⋅David Roodman, G. David⋅Chirgwin, John M⋅Chirgwin, John M and Chirgwin, John M
Blood, vol. 122, (no. 21), pp. 1893, 2013-11-15. | Journal Article
 
Role Of CD166 In Multiple Myeloma Cell Homing To The Bone Marrow Microenvironment and Disease Progression
Xu, Linlin⋅Xu, Linlin⋅Xu, Linlin⋅Xu, Linlin⋅Xu, Linlin⋅Machal, Christophe⋅Machal, Christophe⋅Machal, Christophe⋅Machal, Christophe⋅Machal, Christophe⋅Wu, Hao⋅Wu, Hao⋅Wu, Hao⋅Wu, Hao⋅Wu, Hao⋅Poteat, Bradley⋅Poteat, Bradley⋅Poteat, Bradley⋅Poteat, Bradley⋅Poteat, Bradley⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Cardoso, Angelo A⋅Cardoso, Angelo A⋅Cardoso, Angelo A⋅Cardoso, Angelo A⋅Cardoso, Angelo A⋅Chirgwin, John M⋅Chirgwin, John M⋅Chirgwin, John M⋅Chirgwin, John M⋅Chirgwin, John M⋅Hanenberg, Helmut⋅Hanenberg, Helmut⋅Hanenberg, Helmut⋅Hanenberg, Helmut⋅Hanenberg, Helmut⋅Mohammad, Khalid S⋅Mohammad, Khalid S⋅Mohammad, Khalid S⋅Mohammad, Khalid S⋅Mohammad, Khalid S⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Srour, Edward F⋅Srour, Edward F⋅Srour, Edward F⋅Srour, Edward F and Srour, Edward F
Blood, vol. 122, (no. 21), pp. 3102, 2013-11-15. | Journal Article
 
Temozolomide-mediated DNA methylation in human myeloid precursor cells: differential involvement of intrinsic and extrinsic apoptotic pathways.
Wang, Haiyan⋅Wang, Haiyan⋅Cai, Shanbao⋅Cai, Shanbao⋅Ernstberger, Aaron⋅Ernstberger, Aaron⋅Bailey, Barbara J⋅Bailey, Barbara J⋅Wang, Michael Z⋅Wang, Michael Z⋅Cai, Wenjing⋅Cai, Wenjing⋅Goebel, W Scott⋅Goebel, W S⋅Czader, Magdalena B⋅Czader, Magdalena B⋅Crean, Colin⋅Crean, Colin⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Shokolenkoc, Inna⋅Shokolenkoc, Inna⋅Wilson, Glenn L⋅Wilson, Glenn L⋅Baluyut, Arthur R⋅Baluyut, Arthur R⋅Mayo, Lindsey D⋅Mayo, Lindsey D⋅Pollok, Karen E and Pollok, Karen E
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 19, (no. 10), pp. 2699-709, 2013/May/15. | Journal Article
 
Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.
Blau, Gary E⋅Orcun, Seza⋅Laínez, José M⋅Reklaitis, Gintaras V⋅Suvannasankha, Attaya⋅Fausel, Chris and Anaissie, Elias J
Pharmacotherapy, vol. 33, (no. 7), pp. 727-35, 2013/Jul. | Journal Article
2012
Abstract 5300: Endothelial colony forming cells (ECFCs) in multiple myeloma
Sharma, Rohan⋅Suvannasankha, Attaya⋅Crean, Colin and Yoder, Mervin
Cancer Research, vol. 72, (no. 8 Supplement), pp. 5300, 2012-04-15. | Journal Article
 
A Noncanonical Flt3ITD/NF- Kappa B Signaling Pathway Represses DAPK1 in Acute Myeloid Leukemia
Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Gade, Padmaja⋅Gade, Padmaja⋅Wilson-Weekes, Annique⋅Wilson-Weekes, Annique⋅Sayar, Hamid⋅Sayar, Hamid⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Goswami, Chirayu⋅Goswami, Chirayu⋅Li, Lang⋅Li, Lang⋅Gupta, Sushil⋅Gupta, Sushil⋅Cardoso, Angelo⋅Cardoso, Angelo⋅Al Baghdadi, Tareq⋅Al Baghdadi, Tareq⋅Sargent, Katie⋅Sargent, Katie⋅Cripe, Larry⋅Cripe, Larry⋅Kalvakolanu, Dhananjaya⋅Kalvakolanu, Dhananjaya⋅Boswell, HScott and Boswell, HScott
Clinical Cancer Research, vol. 18, (no. 2), pp. 369, 20120115. | Journal Article
 
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam, Rajasubramaniam⋅Gade, Padmaja⋅Wilson-Weekes, Annique⋅Sayar, Hamid⋅Suvannasankha, Attaya⋅Goswami, Chirayu⋅Li, Lang⋅Gupta, Sushil⋅Cardoso, Angelo A⋅Al Baghdadi, Tareq⋅Sargent, Katie J⋅Cripe, Larry D⋅Kalvakolanu, Dhananjaya V and Boswell, H S
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 18, (no. 2), pp. 360-9, 2012/Jan/15. | Journal Article
 
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.
Benson, Don M⋅Hofmeister, Craig C⋅Padmanabhan, Swaminathan⋅Suvannasankha, Attaya⋅Jagannath, Sundar⋅Abonour, Rafat⋅Bakan, Courtney⋅Andre, Pascale⋅Efebera, Yvonne A⋅Tiollier, Jérôme⋅Caligiuri, Michael A and Farag, Sherif S
Blood, vol. 120, (no. 22), pp. 4324-33, 2012/Nov/22. | Journal Article
 
A Phase I/II Trial Combining High-Dose Lenalidomide with Melphalan and Autologous Transplant for Multiple Myeloma: A Report of the Phase I Dose-Finding Study
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif⋅Silbermann, Rebecca⋅Silbermann, Rebecca⋅Silbermann, Rebecca⋅Obryant, Robin⋅Obryant, Robin⋅Obryant, Robin⋅Wood, Lisa l⋅Wood, Lisa l⋅Wood, Lisa l⋅Huljak, Abigail⋅Huljak, Abigail⋅Huljak, Abigail⋅Secrest, Angie⋅Secrest, Angie⋅Secrest, Angie⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Abonour, Rafat⋅Abonour, Rafat and Abonour, Rafat
Blood, vol. 120, (no. 21), pp. 3146, 2012-11-16. | Journal Article
 
Early Evidence of Anabolic Bone Activity of BHQ880, a Fully Human Anti-DKK1 Neutralizing Antibody: Results of a Phase 2 Study in Previously Untreated Patients with Smoldering Multiple Myeloma At Risk for Progression
Munshi, Nikhil C⋅Munshi, Nikhil C⋅Abonour, Rafat⋅Abonour, Rafat⋅Beck, Joseph T⋅Beck, Joseph T⋅Bensinger, William⋅Bensinger, William⋅Facon, Thierry⋅Facon, Thierry⋅Stockerl-Goldstein, Keith⋅Stockerl-Goldstein, Keith⋅Baz, Rachid⋅Baz, Rachid⋅Siegel, David S⋅Siegel, David S⋅Neben, Kai⋅Neben, Kai⋅Lonial, Sagar⋅Lonial, Sagar⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Bilic, Sanela⋅Bilic, Sanela⋅Chica, Sandra⋅Chica, Sandra⋅Mukhopadhyay, Subhendu⋅Mukhopadhyay, Subhendu⋅Isaacs, Randi⋅Isaacs, Randi⋅Jagannath, Sundar and Jagannath, Sundar
Blood, vol. 120, (no. 21), pp. 331, 2012-11-16. | Journal Article
 
Individualizing the starting dose for MPT therapy in elderly myeloma patients
Blau, Gary E⋅Orcun, Seza⋅Lainez, Jose Miguel⋅Reklaitis, Gintaras V⋅Suvannasankha, Attaya⋅Fausel, Christopher A⋅Kiel, Patrick and Anaissie, Elias J
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. e18555, 2012-05-20. | Journal Article
2011
A Potential Biomarker Panel of Multiple Myeloma Identified Using Label-Free Mass Spectrometry-Based Quantitative Proteomics
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Sahm, Heather M⋅Sahm, Heather M⋅Sahm, Heather M⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif⋅Wang, Mu⋅Wang, Mu and Wang, Mu
Blood, vol. 118, (no. 21), pp. 2890, 2011-11-18. | Journal Article
 
Assessment of Free Light Chains in the Ascites and Pleural Effusion in Patients with Multiple Myeloma: A Report of 2 Cases
Rashdan, Sawsan⋅Rashdan, Sawsan⋅Farag, Sherif⋅Farag, Sherif⋅Abonour, Rafat⋅Abonour, Rafat⋅Suvannasankha, Attaya and Suvannasankha, Attaya
Blood, vol. 118, (no. 21), pp. 5078, 2011-11-18. | Journal Article
 
Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience.
Abonour, Rafat⋅Kramer, G⋅Suvannasankha, Attaya and Benson, M D
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, vol. 18 Suppl 1, pp. 151, 2011/Jun. | Journal Article
 
The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
Zhang, Shuhong⋅Zhang, Shuhong⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅White, Valerie L⋅White, Valerie L⋅Chen, Ching Shih⋅Chen, Ching‐Shih⋅Farag, Sherif S and Farag, Sherif S
International Journal of Cancer, vol. 129, (no. 1), pp. 204-213, 2011. | Journal Article
2010
Assessment of the Performance of Serum Heavy Chains Immunoassay to Monitor Response to Treatment and Its Correlation with Other Tumor Measurements In Serial Samples From Patients with Newly Diagnosed MM
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Farag, Sherif⋅Farag, Sherif⋅Harding, Stephen⋅Harding, Stephen⋅Durie, Brian GM⋅Durie, Brian GM⋅Abonour, Rafat and Abonour, Rafat
Blood, vol. 116, (no. 21), pp. 2986, 2010-11-19. | Journal Article
 
Clinical Activity of a Novel Multiple Tyrosine Kinase and Aurora Kinase Inhibitor, ENMD-2076, Against Multiple Myeloma: Interim Phase I Trial Results
Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅O'Bryant, Robyn⋅O'Bryant, Robyn⋅O'Bryant, Robyn⋅Lisa, Wood⋅Lisa, Wood⋅Lisa, Wood⋅Gupta, Sushil⋅Gupta, Sushil⋅Gupta, Sushil⋅Bray, Mark⋅Bray, Mark⋅Bray, Mark⋅Sidor, Carolyn Fowler⋅Sidor, Carolyn Fowler⋅Sidor, Carolyn Fowler⋅Abonour, Rafat⋅Abonour, Rafat and Abonour, Rafat
Blood, vol. 116, (no. 21), pp. 1957, 2010-11-19. | Journal Article
 
IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody for Multiple Myeloma: Interm Phase 1 Trial Results and Correlative Biologic and Safety Data
Benson, Don M⋅Benson, Don M⋅Bakan, Courtney E⋅Bakan, Courtney E⋅Padmanaban, Swaminathan⋅Padmanaban, Swaminathan⋅Abonour, Rafat⋅Abonour, Rafat⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Chari, Ajai⋅Chari, Ajai⋅Clever, David⋅Clever, David⋅Kalu, Chidimma⋅Kalu, Chidimma⋅Collins, Shauna⋅Collins, Shauna⋅Alghothani, Yousef⋅Alghothani, Yousef⋅Hofmeister, Craig C⋅Hofmeister, Craig C⋅Efebera, Yvonne⋅Efebera, Yvonne⋅Blanchet, Stephane⋅Blanchet, Stephane⋅Caligiuri, Michael A⋅Caligiuri, Michael A⋅Farag, Sherif and Farag, Sherif
Blood, vol. 116, (no. 21), pp. 1966, 2010-11-19. | Journal Article
 
Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Farag, Sherif⋅Farag, Sherif⋅Obryant, Robin⋅Obryant, Robin⋅Wood, Lisa l⋅Wood, Lisa l⋅Porter, Nicole⋅Porter, Nicole⋅Abonour, Rafat and Abonour, Rafat
Blood, vol. 116, (no. 21), pp. 1970, 2010-11-19. | Journal Article
 
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma
Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Sinn, Anthony⋅Sinn, Anthony⋅Sinn, Anthony⋅Sinn, Anthony L⋅Pollok, Karen⋅Pollok, Karen⋅Pollok, Karen⋅Pollok, Karen⋅Sandusky, George⋅Sandusky, George⋅Sandusky, George⋅Sandusky, George⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Crean, Colin D⋅Crean, Colin⋅Crean, Colin⋅Crean, Colin⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Bray, Mark⋅Bray, Mark⋅Bray, Mark R⋅Bray, Mark⋅Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif and Farag, Sherif S
British Journal of Haematology, vol. 150, (no. 3), pp. 313-325, 2010. | Journal Article
2009
Multiple Myeloma Derived Factors Generate Tolerogenic Dendritic Cells by Activation of STAT3: A Potential Target for Immunotherapy
Homsi, Yaser⋅Homsi, Yaser⋅Homsi, Yaser⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Farag, Sherif⋅Farag, Sherif and Farag, Sherif
Blood, vol. 114, (no. 22), pp. 3031, 2009-11-20. | Journal Article